Cargando…

Why do people take part in atrial fibrillation screening? Qualitative interview study in English primary care

OBJECTIVES: There is insufficient evidence to support national screening programmes for atrial fibrillation (AF). Nevertheless, some practitioners, policy-makers and special interest groups have encouraged introduction of opportunistic screening in primary care in order to reduce the incidence of st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoare, Sarah, Powell, Alison, Modi, Rakesh Narendra, Armstrong, Natalie, Griffin, Simon J, Mant, Jonathan, Burt, Jenni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928318/ https://www.ncbi.nlm.nih.gov/pubmed/35296474 http://dx.doi.org/10.1136/bmjopen-2021-051703

Ejemplares similares

Why do people choose not to take part in screening? Qualitative interview study of atrial fibrillation screening nonparticipation
por: Hoare, Sarah, et al.
Publicado: (2023)

Delivering screening programmes in primary care: protocol for a scoping and systematic mixed studies review
por: Modi, Rakesh Narendra, et al.
Publicado: (2021)

How to embed qualitative research in trials: insights from the feasibility study of the SAFER trial programme
por: Powell, Alison, et al.
Publicado: (2022)

Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial
por: Williams, Kate, et al.
Publicado: (2022)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
por: Hobbs, F D R, et al.
Publicado: (2011)

Home care and end-of-life hospital admissions: a retrospective interview study in English primary and secondary care
por: Hoare, Sarah, et al.
Publicado: (2019)

Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians
por: Decker, Carole, et al.
Publicado: (2012)

Management of atrial fibrillation in patients taking targeted cancer therapies
por: Asnani, Aarti, et al.
Publicado: (2017)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021)

Potential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care
por: Harris, K, et al.
Publicado: (2013)

Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists
por: Roldán, Vanessa, et al.
Publicado: (2022)

GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice
por: Kuberska, Karolina, et al.
Publicado: (2021)

Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
por: Jeong, Hoyoung, et al.
Publicado: (2021)

Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators
por: Sheridan, Rebecca, et al.
Publicado: (2020)

Why People Take Medicine
Publicado: (1885)

Anticoagulation trends in adults aged 65 years and over with atrial fibrillation: a cohort study
por: Lund, Jenny, et al.
Publicado: (2021)

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
por: Friberg, Leif, et al.
Publicado: (2019)

Impact of anemia on major bleeding in patients taking oral anticoagulants for nonvalvular atrial fibrillation
por: Kinjo, Norito, et al.
Publicado: (2023)

A case of atrial fibrillation complicated by complete atrioventricular block
por: Yanagisawa, Yuuki, et al.
Publicado: (2023)

Correction to: Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators
por: Sheridan, Rebecca, et al.
Publicado: (2020)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Szpotowicz, Anna, et al.
Publicado: (2021)

Why young people stop taking their attention deficit hyperactivity disorder medication: A thematic analysis of interviews with young people
por: Titheradge, Daniel, et al.
Publicado: (2022)

Why Children are Taking Up the Job?
por: Wadgave, Hanmanta V, et al.
Publicado: (2013)

Screening for Atrial Fibrillation: Improving Efficiency of Manual Review of Handheld Electrocardiograms (†)
por: Pandiaraja, Madhumitha, et al.
Publicado: (2020)

Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants
por: Shao, Iris Yuefan, et al.
Publicado: (2021)

Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban
por: Chao, Tze-Fan, et al.
Publicado: (2022)

Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration
por: Wang, Ruoting, et al.
Publicado: (2022)

Effect of current smoking on ischemic events in patients with atrial fibrillation taking vitamin K antagonist
por: Arai, Hideki, et al.
Publicado: (2022)

Helping themselves and helping others: how the passage of time influences why mothers with addictions take part in research
por: Crawford, Karen, et al.
Publicado: (2023)

Temporal trends in incidence of atrial fibrillation in primary care records: a population-based cohort study
por: Mendonça, Sílvia C, et al.
Publicado: (2020)

Why patients want to take or refuse to take antibiotics: an inventory of motives
por: Bagnulo, Adriana, et al.
Publicado: (2019)

Advances in the management of atrial fibrillation in congestive heart failure
por: Gopinathannair, Rakesh, et al.
Publicado: (2009)

Why Do People (Not) Take Breaks? An Investigation of Individuals’ Reasons for Taking and for Not Taking Breaks at Work
por: Phan, Vincent, et al.
Publicado: (2022)

Targeted Atrial Fibrillation Therapy and Risk Stratification Using Atrial Alternans
por: Muthavarapu, Neha, et al.
Publicado: (2023)

The heavy LEGACY: Should weight management be part of every atrial fibrillation clinic?
por: Atreya, Auras R., et al.
Publicado: (2015)

Why are there long waits at English emergency departments?
por: Gaughan, James, et al.
Publicado: (2019)

Early experience of thoracoscopic vs. catheter ablation for atrial fibrillation
por: Pearman, Charles M, et al.
Publicado: (2019)

Biomarkers and the prediction of atrial fibrillation: state of the art
por: O’Neal, Wesley T, et al.
Publicado: (2016)

Taking the next step in documentation: Why and how?
por: Aggarwal, Himanshi, et al.
Publicado: (2014)

Why are self-medication opportunities limited in Austria? An interview study and comparison with other countries
por: Gauld, Natalie J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jcvc4dek2er5q89d9r6sqa9ni5